Analysis for KMB
- 📈 Growth — 6/30
- 💰 Profitability — 15/20
- 🏦 Financial Health — 9/20
- 💵 Valuation — 12/20
- ⚠️ Risk — 6/10
Summary:
📈 Growth & Financial Trajectory
Over eight quarters from 2024 Q3 to 2026 Q2, Revenues moved from about $4.93B to $4.19B, a decline of ~15%. Net Income also declined from roughly $573M to about $350M, with quarterly fluctuations. The path shows an initial drop in late 2024, a partial rebound through 2025, but an overall lower level by Q2 2026, indicating muted growth despite a stable operating margin.
💰 Margins & Cash Flow
Gross Margin rose from the low 30s% toward the high-30s% and even around mid-40% in early 2025, while Operating Margin has hovered in the 15-19% range. Operating cash flow remained positive in all quarters, typically in the hundreds of millions to near $1B, with investing activities often negative and financing activity variable, yielding modest net cash flow in several quarters.
🛡️ Balance Sheet & Liquidity
Total assets run about $16.8B–$18.6B; liabilities about $15.4B–$16.8B and equity around $1.0B–$2.0B. The Current Assets ($5.3B–$5.6B) vs Current Liabilities ($7.0B–$7.1B) give a current ratio below 1, signaling tighter near-term liquidity, though the company sustains positive operating cash flow and substantial asset base.
⚠️ Key Drivers & Risks
- Drivers: Defensive consumer staples demand, scale efficiencies, and ongoing cost management.
- Risks: Leverage sensitivity (debt levels vs equity) and liquidity constraints, plus input cost volatility affecting margins.